Herpes simplex viruses (HSV) belong to a family of oncogenic viruses. They cause moderate to severe disease, particularly in neonates, infection or drug induced immunologically deficient individuals including cancer patients and are associated as co- factors with human cancer of the cervix. A key property is their ability to remain latent in sensory or autonomic neurons and to cause recurrent lesions after spontaneous or induced activation of viral replication. This application consolidates four long standing interdigitated projects centering on the molecular biology of these viruses. The key components of these projects are as follows: (i) The HSV genome consists of two covalently linked double stranded DNA components flanked by inverted repeats. The terminal a sequence shared by both components contains the cis sites for the inversion of the two components relative to each other, for the excision of the genome from multimeric head to tail concatemers, for packaging of the DNA into capsids, and for the circularization of the DNA. The a sequence contains the transcription initiation site and the promoter of a gene whose coding sequence are in the repeats of the long component. These studies will be continued to identify the viral trans-acting factors that specifically bind to the a sequence and to determine their function by mutage- nesis of their genes and of their cis-acting sites. (ii) Technology has been developed and applied to demonstrate that all but one gene mapping in the unique sequences of the small (S) component are dispensable with respect to viral growth in cell culture. The intent is to continue the analyses of the viral genome for dispensable genes, to determine their function, and to determine the function of a new essential gene which contain in its domain the S component origins of DNA synthesis. (iii) HSV genes form three major groups alpha, beta, and gamma whose expression is regulated in a cascade fashion. The alpha genes are induced by a structural component of the virion but that the cis-acting site required for the induction of the alpha genes binds two host proteins. The plan is to continue to characterize the interaction of the viral factor with these proteins and to determine the role of these proteins in the induction of alpha genes, as well as the role of the major regulatory protein, alpha 4, in the regulation of beta and gamma genes. (iv) Only a subset of viral genes in expressed during latent infection of neurons. The objectives are to genetically engineer novel genomes to determine why the full complement of viral genes is not expressed during latency.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
5R35CA047451-05
Application #
3479674
Study Section
Special Emphasis Panel (SRC (88))
Project Start
1988-05-15
Project End
1995-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Kawaguchi, Y; Tanaka, M; Yokoymama, A et al. (2001) Herpes simplex virus 1 alpha regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc Natl Acad Sci U S A 98:1877-82
Lopez, P; Van Sant, C; Roizman, B (2001) Requirements for the nuclear-cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1. J Virol 75:3832-40
Zhou, G; Roizman, B (2001) The domains of glycoprotein D required to block apoptosis depend on whether glycoprotein D is present in the virions carrying herpes simplex virus 1 genome lacking the gene encoding the glycoprotein. J Virol 75:6166-72
Van Sant, C; Lopez, P; Advani, S J et al. (2001) Role of cyclin D3 in the biology of herpes simplex virus 1 ICPO. J Virol 75:1888-98
Ward, P L; Taddeo, B; Markovitz, N S et al. (2000) Identification of a novel expressed open reading frame situated between genes U(L)20 and U(L)21 of the herpes simplex virus 1 genome. Virology 266:275-85
Advani, S J; Weichselbaum, R R; Roizman, B (2000) The role of cdc2 in the expression of herpes simplex virus genes. Proc Natl Acad Sci U S A 97:10996-1001
Markovitz, N S; Roizman, B (2000) Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present. J Virol 74:523-8
Galvan, V; Brandimarti, R; Munger, J et al. (2000) Bcl-2 blocks a caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 infection in HEp-2 cells. J Virol 74:1931-8
Markovitz, N S; Roizman, B (2000) Replication-competent herpes simplex viral vectors for cancer therapy. Adv Virus Res 55:409-24
Ye, G J; Roizman, B (2000) The essential protein encoded by the UL31 gene of herpes simplex virus 1 depends for its stability on the presence of UL34 protein. Proc Natl Acad Sci U S A 97:11002-7

Showing the most recent 10 out of 136 publications